trimetazidine has been researched along with enalapril in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bakhmatova, IuA; Gapon, LI; Kalinina, VA; Kuznetsov, VA; Petelina, TI; Todosiĭchuk, VV; Zhevagina, IA | 1 |
| Bakhmatova, IuA; Gapon, LI; Petelina, TI; Zhevagina, IA | 1 |
| Akdemir, O; Ates, U; Cavusoğlu, T; Erbas, O; Karadeniz, M; Karadeniz, T; Tuglu, MI; Turkmen, E; Uyanıkgil, Y | 1 |
2 trial(s) available for trimetazidine and enalapril
| Article | Year |
|---|---|
[Anti-ischemic efficacy of combination of trimetazidine with enalapril in patients with stable effort angina and metabolic syndrome].
Topics: Adult; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2005 |
[Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Catalase; Comorbidity; Drug Therapy, Combination; Enalapril; Female; Humans; Hypercholesterolemia; Hypertension; Lipid Peroxidation; Male; Middle Aged; Myocardial Ischemia; Severity of Illness Index; Trimetazidine; Vasodilator Agents | 2005 |
2 other study(ies) available for trimetazidine and enalapril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Trimetazidine | 2014 |